Abacus Global Management, Inc. (ABX) Earnings Call Transcript & Summary
May 7, 2026
Earnings Call Speaker Segments
Robert Phillips
executiveThanks, operator, and I appreciate all of you being on the line for Abacus Global Management's earnings call covering the first quarter. Joining me are Jay Jackson, our Chairman and Chief Executive Officer, Elena Plesco, our Chief Investment Officer, and Bill McCauley, our Chief Financial and Chief Operating Officer. At 4:15 P.M. Eastern Time today, Abacus Global Management put out its results for the first quarter of 2026. On this afternoon's call, anyone taking part can pose questions regarding those results. Prior to getting started, Abacus Global Management directs those listening to the investor webpage at ir.abacusgm.com, where the press release, investor information, and SEC filings can be found, for a conversation about the risks capable of impacting the business. Abacus Global Management points listeners specifically to the presentation furnished today on Form 8-K with the Securities and Exchange Commission, and wants to remind everyone that certain remarks made today might include forward-looking statements and therefore will carry risks and uncertainties that, should they come to pass, could materially affect results. For additional details on the risks, uncertainties, and assumptions tied to forward-looking statements, please consult Abacus Global Management's public filings. Throughout this call, we will mention specific non-GAAP financial measures. While we believe these measures offer helpful supplemental information concerning our financial performance, they are not recognized measures and lack standardized meanings under U.S. generally accepted accounting principles, or GAAP. Please review our public filings for further information about our non-GAAP financial measures, including references to comparable GAAP measures. Having said that, I would now like to hand the call over to Jay Jackson, Abacus Global Management's Chairman and Chief Executive Officer.
Jay Jackson
executiveRob, thanks, and good afternoon to everyone joining us. I've had the opportunity to speak with many of you over the weeks following our fourth-quarter call, so I'll keep my remarks brief and focused. I'll begin with the headline. Based on what we're seeing in the business today, we're raising our full-year 2026 adjusted net income outlook from $96 million-$104 million to $100 million-$106 million, which moves both ends of the range higher. At the new range, that comes to $1.00-$1.05 in adjusted EPS. Several drivers we're watching in real time give us the conviction behind this move. Into our longevity funds, we brought in $288 million this quarter, which comes on top of the $275 million during Q4. For context, across the entirety of 2025 we raised $630 million. The step change in fundraising that showed up at year-end has moved cleanly into the new year, and our pipeline keeps expanding. During Q1 by itself, we looked at almost 9,000 qualified policies, versus about 11,000 for all of 2025. The flywheel is doing precisely what it was built to do. More assets under management fuel origination, and our infrastructure is keeping up with that demand. Because we can see the near term this clearly, we feel comfortable providing guidance for the upcoming quarter alongside our range for the entire year. Looking at Q2 2026, our expectation is adjusted net income between $24 million and $26 million, which works out to adjusted EPS of $0.24 to $0.26. I'd like to spend a moment on how the year is shaped, since the rapid expansion of recent years has masked a pattern that's simply normal for how we do business. Money doesn't come in at a steady pace each quarter. Our slowest month is usually January, then things pick up in February and March, and after that we run at a strong clip through the spring and summer months. Typically, August sees less activity on both the deployment and fundraising fronts, since things tend to pick back up once autumn arrives and carry through to a robust close in Q4. Our Q1 ANI came in at $20 million. For Q2, guidance sits between $24 million and $26 million. Since the latter half of the year has traditionally delivered our best results, that's what supports the increased range we've set for the full year. Bill will walk everyone through operations and the financials, and you'll notice that strength reflected in the metrics that count. Elena will address our KPIs along with capital allocation. Before that, I want to lay out two forces that, in my view, shape where Abacus stands right now. The first concerns the current macro backdrop and its implications for the asset class we operate in. The fog of doubt hanging over the first quarter has brought us to a pivotal juncture for the whole alternatives sector. People who invest are reconsidering the destinations for their money. They're moving into holdings that genuinely have no link to how markets feel or to the credit cycle. Abacus delivers precisely that. Mortality is the source of our yield, not interest rates; as a result, what we return carries no structural correlation. During this quarter, that unique quality drew funds our way in a substantial manner. Our AUM climbed steeply over Q1, powered by inflows from investors who understand the point: private credit is not what we are — we're the alternative they choose in its place. There's a point I need to make sure investors grasp fully, and that's how greater demand ties to purchase discount rates. With more institutional money entering this asset class, buyers are bidding against each other harder for policies. When buyers compete, they shell out more per policy, and that feeds straight into reduced purchase discount rates. Let me state this as strongly as I can. In our line of work, a decline in the purchase discount rate is good news; it signals that asset values are climbing and that long-term spreads on contracts we already own are widening. In our view, this pattern will hold through 2026. The second item I'd like to call out is, in my judgment, among the most significant proof points this company has ever produced; and it took place during this quarter. Our LMA Income II fund arrived at the close of its initial term. We introduced this fund 3 years back, and it expanded to roughly $115 million in assets under management. Once the term wrapped up, we gave capital back to each and every investor who asked for it — 100% on time, exactly as promised. Handing investor capital back when a fund's term ends ought to be standard practice. Throughout today's alternatives sector, that isn't the case. In a period where restrictions on investor capital have become commonplace and redemption gates are now widely accepted, Abacus followed through on our commitments. What makes this even more significant is this: roughly one-third of those investors chose to roll over their investment, and an additional third redeployed their capital into our new products. That goes beyond just keeping capital in place. It represents a strong vote of confidence. Investors who had every option available reviewed this asset and these funds, then made the decision to place more money with us. There is no more powerful validation than that. Bill is going to walk through the balance sheet details in depth, but I'll just note that this transaction reduces the debt we're carrying by more than $75 million, which puts our capital position in even better shape as we move through the remainder of the year. Now, looking forward, there are two transformational growth opportunities I want to highlight that I believe will define Abacus's next chapter. The first one is our investment in Manning & Napier. We keep seeing real momentum build in this relationship. The strategic alliance and the distribution agreements are both coming together, and our teams are already working on integrating the two platforms. Manning's existing infrastructure is strong and well positioned to support what we're building jointly; this is not a passive investment. This distribution alliance should significantly widen how many advisors and their customers can access what we offer. We're looking for the first signs of how it's going during Q2, and once things develop further, we'll share additional details. Next up is what we're doing with securitization. Given how favorably our first securitization turned out, we're now pursuing a second sizable one, targeted for late in Q2 or the beginning of Q3. Securitization serves as a strong tool for us — it allows us to put capital back to work efficiently, diversify our funding sources, and demonstrate to institutional markets just how solid and steady the assets we create are. A second deal in that window would mean a real step-up in the pace of that program and would further confirm this asset class's institutional credibility. As that process moves forward, we'll share updates. With that, I'll hand things over to Bill.
Bill McCauley
executiveAppreciate it, Jay. Two areas are on my list. First, how operations performed across the quarter, and second, what the numbers tell us regarding the momentum Jay walked through. I'll hand things to Elena for the KPIs and capital allocation. Jay already went through the headline drivers for the quarter. What I want to do is dig into the operational specifics beneath them. The deployment volume Jay mentioned came through an origination pipeline that stayed very selective. During Q1 we looked at a large pool of qualified policies and our close rate landed right in line with what we've historically done. Underwriting standards were not loosened in order to satisfy demand. A bigger inflow of applications just handed us a wider set to pick from. Elena will take you through the individual metrics, but the big picture is that volume rose while quality stayed intact. The clearest proof of how all the operational components fit together this quarter shows up in the cash flow statement. Operating cash flow for Q1 2026 came in at $91.7 million, versus -$61.6 million in Q1 2025. That's a year-over-year swing beyond $153 million. Three developments drove it simultaneously. Policies sitting on our balance sheet threw off cash via trading and maturities. The LMA Income II fund wrapped up its initial term and returned capital. And the platform's inherent operating leverage kicked in as revenue scaled without a matching rise in cash costs. Whether a model truly works ultimately comes down to cash conversion, and Q1 cleared that bar convincingly. As for the portfolio, the brief version is that both quality and margin are running ahead of plan. Realized gains this quarter came in above our 20% long-term benchmark, and our seasoned assets keep appreciating consistent with actuarial assumptions. Elena will cover the detailed KPIs — turnover, weighted average life expectancy, and insured age — but the direction is uniformly positive. On LMA Income II, Jay went through the fund outcome and what it signals for investor confidence. Let me add the financial reporting piece. Given the fund's initial structure, GAAP required us to consolidate it as debt on our balance sheet. Now that the fund's initial term has concluded this quarter, that obligation comes off. The upshot is a drop of over $75 million in reported balance sheet debt. Let me be precise here; this isn't a corporate deleveraging event. What it represents is the removal of a fund level consolidation from our balance sheet. Practically speaking, our reported leverage ratios improve materially with no shift whatsoever in our underlying capital structure. I'll get into the specific metrics next in the financial section. Moving to our financial results, total revenue for the first quarter rose 34.6% to $59.4 million, up from $44.1 million in the prior year period. The growth came mainly from strong performance in Life Solutions, which brought in $50.6 million, plus continued expansion in asset management fees, which hit $8.5 million, reflecting growth in fee-paying AUM across our longevity fund strategies. Our technology services segment brought in $0.4 million, which reflects where we are in the early-stage build-out of that business. Now, on the expense side, total operating expenses came to roughly $34.8 million for the first quarter. That compares with $19.6 million a year earlier, once you exclude the gain on change in fair value of debt and the gain on equity securities. What drove that year-over-year increase? Mainly it was more spending on sales and marketing to support our distribution build-out, plus higher G&A tied to our platform investments, business acquisition, and special project expenses. These are intentional investments we're making in the growth profile of the business. On an adjusted basis, which excludes non-cash stock compensation, business acquisition and special project costs, amortization, and changes in the fair value of investments, adjusted net income for the first quarter rose 16.6% to $20.1 million, up from $17.3 million the prior year. Adjusted EBITDA for the quarter increased 33.3% to $32.7 million, versus $24.5 million the prior year. Our adjusted EBITDA margin came in at 55% for the quarter, compared to 56% the prior year. We're committed to growing this business responsibly, and that's shown by our ability to grow revenue and EBITDA by over 30% while keeping margins in that range. GAAP net income attributable to Abacus Global Management for the quarter was $7.3 million, or $0.07 per diluted share, compared to $4.6 million, or $0.05 per diluted share, in the prior year period — growth of 59%. Now moving to our balance sheet: for Q1, adjusted return on equity was 19% and adjusted return on invested capital was 17%, with both improving from Q1 2025. As of March 31, 2026, the company held cash of $37.2 million, balance sheet policy assets of $392.8 million, and outstanding long-term debt of approximately $330 million. The drop in reported debt from $405.8 million at year-end reflects the conclusion of the initial term for the LMA Income II fund I mentioned earlier, which took roughly $76.7 million in fund-level reporting obligations off our balance sheet. To sum up, we're very pleased with our strong start to 2026. We delivered meaningful top-line growth, sustained profitability, and a strengthened balance sheet, all while continuing to invest in the platform initiatives that will drive the next chapter of this company's growth. With that, I'll hand it over to Elena.
Elena Plesco
executiveThank you, Bill. Today I'd like to cover two topics with my time: first, how the balance sheet did over the quarter, and second, our thinking on capital allocation here at Abacus. Starting with balance sheet results, in Q1 our annualized portfolio turnover came in at 1.9 x, which sits right within our long-term target range of 1.5x-2x. For the quarter, our average realized gain was 26%. Those margins, which beat our 20% objective, are a product of disciplined origination, careful actuarial targeting, and patience. Portfolio quality remains solid. Assets that have seasoned past 365 days carried a weighted average life expectancy of 46 months and a weighted average insured age of 88 years, versus 45 months and 88 years in the prior quarter. Such positions demonstrate our underwriting conviction. As they keep seasoning, we anticipate they will deliver attractive returns. In Q1, we put $163.6 million of capital to work off our balance sheet. More than 9,000 qualified policies were reviewed by our origination platform this quarter. We stay very selective; this figure shows how deep our pipeline runs, since we looked at a little under 11,000 policies in total last year. I'd like to devote the rest of my time to our approach to capital allocation, because I think it's among the most critical things for our shareholders to grasp about this business. We split capital allocation into two buckets: operating and investing. Day-to-day operations of the business are funded by operating capital. That covers buying policies, acquiring other operating assets, and financing organic growth throughout our platform. Investing capital is essentially all the rest. It includes returning capital to shareholders via dividends and buybacks, pursuing strategic M&A, and backing the growth of our asset management business, whether that's seeding new fund strategies, supporting our securitization program, or building the infrastructure for AUM expansion. These priorities don't compete with one another. They are deliberately sequenced, and our aim is to make sure we retain the flexibility to execute both effectively. As for where our capital originates, our balance sheet is the starting point; we see our active balance sheet, our managed assets, as roughly $450 million in cash and liquid assets that we turn into cash quickly through our typical origination to monetization cycle. That's the business's core funding mechanism, and it sustains itself. Growing our core Life Solutions business doesn't require additional balance sheet capital. On top of that, we have two external levers, debt and equity; regarding debt, we are currently meaningfully under-levered. Our recourse debt-to-EBITDA ratio is about 2x, against capacity we think reaches 4x; this leaves us substantial additional borrowing room to put into high-returning opportunities without diluting shareholders. As for equity, we aren't seeking to raise primary capital apart from any possible M&A activity. Our business produces the cash flow needed to finance its own growth, and we plan to keep things that way. Stepping back and looking at the business now, the story is simple. Life Solutions has a core origination engine that keeps delivering strong results, backed by careful underwriting and steady monetization. Beyond that, we are constructing an asset management platform built to scale, one meant to produce rising fee-related earnings via our longevity funds, our ETFs, our asset-based finance strategy, plus ongoing growth of our distribution capabilities. Since we began, the new vintage of longevity funds has drawn close to $1 billion in capital from investors. Expanding fee-related earnings stays a top priority. As fee-paying assets grow across our strategies, we bring in contractual, high-margin management fee income without needing extra balance sheet capital. Our capital allocation framework exists to make sure each dollar we put to work, whether in operations or investments, moves us toward that goal. We are carrying this out intentionally, one step at a time, with a long-term view, and we believe this approach will keep creating value for our shareholders. With that, I'll hand things to Jay for closing remarks.
Jay Jackson
executiveLooking back on this quarter, what stands out isn't any one result, but rather how everything we have been building toward is coming together. Capital keeps entering this asset class because investors want precisely what we offer: consistent, predictable, uncorrelated returns. Our operational infrastructure is keeping pace with that demand, our funds are delivering, and our strategic initiatives are putting us in position to capture a far bigger slice of the opportunity ahead. The foundation is solid, and the trajectory is evident. These initiatives amount to the sort of strategic scaling that takes a company from small cap to mid cap. We are acting with urgency and conviction alike. I want to thank our investors for their ongoing confidence, our team for outstanding execution this quarter, and our partners for their dedication to what we are building. We look forward to sharing updates on our progress and delivering on the opportunity this moment represents. We will now hand it to the operator for any questions.
Patrick Davitt
analystHello there, and good evening to all of you. Starting off with the topic of flows: you mention in the release that the second securitization might be pushed into the third quarter, so if it actually landed in the second quarter instead, would that add on top of the $500 million of inflows you expect for the first half?
Jay Jackson
executiveHey, Patrick. Yes, it would come on top of that $500 million.
Patrick Davitt
analystAll right, excellent. Can you bring us up to speed on the status of the interval fund's SEC review?
Jay Jackson
executiveOf course. I appreciate the question. We've been putting in serious effort alongside the SEC. Although we're unable to lay out exactly where things stand or how their particular review schedule is shaping up, we're optimistic that we might be in a position to share news during Q2.
Patrick Davitt
analystExcellent. Many thanks. I'll rejoin the line later.
Andrew Kligerman
analystHello there, good afternoon to all of you. Regarding slide 11, I found it quite intriguing. It suggests that over the coming few years, wealth advisors would shift from contributing 0% of revenue to roughly 25%. Could you take us through something like a brief roadmap for how that happens?
Jay Jackson
executiveCertainly.
Andrew Kligerman
analystDoes that 25% figure refer to revenue? Would that be Manning & Napier? Would it be advisors already with us? Are you anticipating—
Jay Jackson
executiveCorrect.
Andrew Kligerman
analystIs a good chunk of that coming from acquisitions? I'm just wondering what the plan looks like on that front.
Jay Jackson
executiveAbsolutely. I appreciate the question, Andrew, and it's good to hear your voice. Yes, the path we've laid out toward the financial advisory, or really the private wealth, segment aligns completely with the idea of either building it ourselves or buying it. There are quite a few opportunities we believe will materialize and assist us in hitting those goals. That first investment in Manning & Napier, in my view, was extremely logical for us as a way to prove and showcase the synergies we've described — sourcing contracts, sending them over, handling them, possibly generating leads for them, and then kind of running those synergies while bringing in extra cash flow from both sides. We're already experiencing some wins there and are very near to wrapping up our strategic alliance agreement, followed by a go-forward agreement. There are quite a few other opportunities involving registered investment advisors that I believe are looking for that same kind of partnership, whether that means taking a minority stake or a full stake, a complete acquisition. The pipeline for that has us genuinely enthusiastic. I believe we'll witness more of it as we move through year-end and definitely with greater intensity going into 2027.
Andrew Kligerman
analystUnderstood. That's quite clear. Now, turning to slide 27, I noticed what seems like a positive shift — the number of days held on policies that were sold rose quite substantially, reaching 290.
Jay Jackson
executiveYes.
Andrew Kligerman
analystCould you perhaps walk us through what sort of benefits you've seen from keeping that position for an extended period? Conversely, the number of days held on the own policies dropped considerably, down to 209. How are you viewing those two measures going forward? Are they sitting where they ought to be?
Jay Jackson
executiveCorrect.
Andrew Kligerman
analystAre you anticipating either of those trends to rise or fall? How do you see things playing out ahead?
Jay Jackson
executiveThanks. I think you hit the key point there at the end — we feel we're sitting in the range we aim for. Looking back at where that has typically landed, whether we're talking about days held or days held through transactions, we're seeing somewhat of a sweet spot in that area. In the previous quarter, we did observe a slight shift, since we'd capitalized on certain contracts that were quite opportunistic and shifted a bigger share of them. My sense is that where we're currently trading is roughly where you ought to expect those figures to begin when thinking about modeling ahead. In the quarter, we came in at approximately 1.9x to 2x on an annualized basis for our book turnover. That, I believe, mirrors the opportunities present in the market. One point I want to call out, though, is that demand for the underlying asset has risen considerably, fueled by its clearly uncorrelated character. When you factor in the volatility observed in other, if you will, adjacent asset classes, this opportunity within this asset class has become notably more attractive to institutional investors who may be seeking somewhat lower yield, yet desire the uncorrelated stability that these policies embody.
Andrew Kligerman
analystGreat. Thank you, Jay.
Jay Jackson
executiveAwesome. Thank you.
Mike Grondahl
analystHello, and thanks. My question concerns those 9,000 policies that were examined.
Jay Jackson
executiveSure.
Mike Grondahl
analystFor the first quarter of 2026 compared with 11,000 during 2025, would you characterize that entirely as organic expansion, entirely inbound? Was there additional marketing spend or anything else behind it?
Jay Jackson
executiveAbsolutely. Appreciate that, Mike. That's a sharp observation. Correct, it is organic. On top of that, from where we sit, I'd call it somewhat opportunistic, because we keep spotting openings while demand persists and more capital comes in tied to our own funds and, of course, funds beyond ours. That pushes supply higher. What I'm genuinely attempting to emphasize is that whenever we keep raising capital across our funds, securitizations, and certain other products, the natural question sometimes arises: can we support that demand with enough policies? Strong evidence from Q1 says we can. A portion of that is flowing into Q2, and we're thrilled about it. This is organic. We aren't exactly dialing up the advertising spend. Compared with a year earlier, I'd say the budget stayed pretty steady during Q1. Beyond that, my view is that the effort put in during 2025, when we did boost our budget — especially in Q3 and Q4 — begins delivering results across Q1, Q2, and Q3.
Mike Grondahl
analystUnderstood. So, you mentioned that increasing asset worth and the need for those policies led to a reduced discount rate on purchases.
Jay Jackson
executiveCorrect.
Mike Grondahl
analystCould you put a number on that for us, Jay — maybe a point or two? How should we gauge it or wrap our heads around it?
Jay Jackson
executiveAbsolutely. The clearest frame, I'd say, is the slide covering our gross trade spread margin, correct? Looking at that figure, my sense is we came in at ±26% for the quarter. That's really the cleanest way to put a figure on it. Sure, you may observe demand climbing, and in most markets, when rising demand pushes prices higher, historically you'd watch those discount rates, or the forecasted purchase rates, tighten up. For us, though, what we're saying is this can actually work in our favor, right? Prices rise, we sell at a higher price, and that demand then generates additional revenue. My argument is that I expect we'll see more of this, right? Consider simply the cash flows coming into our own funds, plus demand from investors hunting for capital sources that, again, are less volatile and correlated — those sorts of, those sorts of traits — and it turns into a positive outcome for us. To be precise, if you tried to reduce this to, you know, a single percentage point, I'd say that's somewhat difficult, since we'll witness it occur in any given quarter. My argument is that whether it's 100 basis points or 200 basis points, in the end it's a positive outcome for us.
Mike Grondahl
analystGot it. Well, thanks a lot.
Jay Jackson
executiveThank you.
Ben Graham
analystBen Graham here, filling in for Crispin Love — hello and good afternoon. Appreciate you taking my question.
Jay Jackson
executiveOf course.
Ben Graham
analystCould you give us a bit more detail on where your head is at with M&A right now — specifically, which kinds of assets interest you most at the moment? Is it mainly the RIA space, tech, or other pockets? Thanks.
Jay Jackson
executiveYeah, absolutely. That's a great question. Our pipeline looks pretty strong at present, and as for where our interest concentrates most, you hit the nail on the head — it's the RIA side. We believe some genuinely compelling opportunities exist in that space. That said, we hold ourselves to a very high bar when choosing. We need to confirm the platform fits who we are culturally, that it turns a profit, and — the single most important point, in my view, for any deal we do — it has to be accretive, correct? It matters enormously that such deals add to our results, on an EPS basis as well as when measured against our synergies; we need to demonstrate that a given acquisition will drive expansion of the business through 2027 and 2028, since I believe that's what shareholders expect from us; on that, we stay extremely disciplined. We're after businesses that are accretive. Turning to our tech platforms, we continue building some quite thrilling capabilities internally that, within roughly the next 60 days, we'll begin announcing. For sure, at our Investor Day, we'll unveil several of them, and those will bring about a genuinely major transformative change across private wealth management. Initiatives of that kind, where lifespan gets woven into financial planning, are now beginning to occur in real time. Adopting various AI platforms to support that work and speed up the process is likewise occurring in real time. As for tech-style platforms we might consider, they'd be the sort capable of supplying data and information to our clients that proves enormously valuable for a tailored solution — be it insurance or financial planning — yet always tied to their longevity data. I recently gave remarks at the Milken Institute about this, and it drew enormous attention, given that $1 trillion of wealth is transferring. Our argument: wouldn't the world prefer to know when that transfer will occur? You can understand that better when you grasp the longevity and lifespan data underpinning it more thoroughly. Companies of that kind strike us as extremely interesting.
Ben Graham
analystGreat, I really appreciate all that detail. Just a quick question about the carrier repurchase plan — I'm curious whether there's anything fresh to mention, any new announcements, what we should expect for the year, and whether any of it is included in the guidance?
Jay Jackson
executiveOf course.
Ben Graham
analystThank you.
Jay Jackson
executiveInterest remains extremely strong, and we are collaborating straight with carriers on structure. Beyond the repurchase, we are likewise engaging and talking with carriers regarding fresh product issuance tied to our underwriting. It's remarkable how this truly is looping back around within our partnerships, plus strategic alliances with carriers and reinsurance firms. When I mention structure in connection with a buyback, certain structural benefits exist that we are navigating alongside some carrier partners, which could genuinely render that buyback more cost-effective and simpler to carry out. That initiative is ongoing for us through 2026, and on top of that, we are expanding certain carrier relationships, possibly even with additional new product sales.
Ben Graham
analystPerfect, that covers everything on my end. I truly appreciate your taking the time to respond to my inquiries.
Jay Jackson
executiveYou're welcome. By the way, that $200 million figure is worth keeping in mind.
Timothy D'Agostino
analystHi there, and thanks for fielding the questions. I hopped on a little late, so I apologize if I'm covering ground that's already been discussed. On slide 26, looking at the capital deployed for policy originations, that number for 1Q is once again above what we had projected. So I'm trying to get a handle on this — back at the start of 2025, I believe it was roughly $120 million. Now that we're seeing $230 million in the fourth quarter and $163 million in the first quarter, do you feel good about that being the run rate going forward, or are you simply capitalizing on opportunities as they come? Thank you.
Jay Jackson
executiveThat's a great question. Sure, it was opportunistic, no doubt about that. But I'd also point out that there was demand for capital that we needed to satisfy with that deployment. When it comes to modeling what a tighter range might look like, we've got a few analysts covering us who've been using a very high figure — though that's not really the correct approach either. From what I can see, our tracking puts us somewhere between 130 and 150, and Q1 was definitely a strong quarter for us. One KPI we keep an eye on is this: that figure could climb above 150, just as it did in Q1, if our gross capital inflows come in higher — right? Here's how I'd frame that. That figure ties back to how much demand exists and how much capital we need to deploy. I don't want to step out and declare, "Go ahead and build your model around 200," since, as I've pointed out, any single quarter can shift things somewhat. What we're far more at ease with is pointing folks toward that 130 to 150 range. Should we come in somewhat above it, the way we did in Q1, wonderful. Beating expectations is always what we're aiming for. That's also the reason we lifted our guidance, isn't it? We attempted to signal something fairly clearly: our outlook for the rest of 2026 looks solid, and that covers money we plan to put to work. Within that 130 to 150 band, we're at ease sitting toward the upper end, so we're raising our guidance to match.
Timothy D'Agostino
analystAll right, that's great. So then, may I pose a follow-up regarding AUM? It was fairly level compared with the prior quarter. I realize that's a brief window — only Q1 — but considering the 2028 target of $30 billion in AUM, could you take us through it once more, specifically what portion arrives organically and what portion comes from inorganic sources? Thank you.
Jay Jackson
executiveYes. The underlying assumption is reaching roughly a 50/50 split by the time 2028 arrives, between organic and inorganic. Inorganic would mean acquisitions, whether via some highly promising chances on the asset management front, plus the private wealth front, as I mentioned earlier. That's how we're charting it. We anticipate seeing more of that happen as we move into 2027. Given certain opportunities sitting in our pipeline, I can say we think we're on pace with that figure.
Timothy D'Agostino
analystAll right, excellent. I really appreciate you fielding our questions today.
Jay Jackson
executiveOf course.
Patrick Davitt
analystHey, thanks for taking the follow-up. I don't believe I came across it in the materials, but what remains available under the repurchase authorization? Given this M&A discussion, could you bring us up to date on your current thinking regarding the stock and buybacks going forward? Thank you.
Jay Jackson
executiveSure. Thank you, Patrick; we've used roughly 50% of that most recent $20 million buyback that the board approved; there's still, I believe, a fair amount of capacity remaining for us to act on; we monitor that carefully. What you've raised matters a lot, since we consider our multiple relative to our earnings, our fairly steady results, particularly compared with how we've looked recently, we just said we're lifting once more our EPS goals for 2026 and then projecting out to 2027, 2028. As for whether we'd pursue additional share repurchases, yes, we would. I think that, you know, we continue to view the market's valuation of our shares as heavily discounted. When we weigh that versus other places we could put capital, right? We're seeing ROIC and ROEs in the high teens, low twenties. You know, we believe that even using our analysts' price targets, we're right now trading at quite a meaningful discount to that. You know, buybacks remain, in our view, a key component of our, you know, the options we might pursue. Where that ties into M&A, you're right? The, you know, share price matters for that. I think that, you know, in the majority of M&A deals, some portion of that involves stock. I think what strikes me is that the transactions currently in our pipeline add to earnings even at today's pricing. Picture if we gained, you know, another 10%, 15%, 20%, 30% in our stock's valuation, those deals would turn out even more accretive. When evaluating a deal today, we're factoring into that M&A that, hey, this reflects a very attractive share price. Does this deal still add to earnings? As our share price keeps building some upward momentum, these transactions will appear even stronger. We believe we're positioned very well when it comes to M&A.
Patrick Davitt
analystThank you.
Jay Jackson
executiveThank you, Patrick.
Jay Jackson
executiveWe appreciate it. Once more, we'd like to say how thankful we are for our partners, the analysts covering us, those who hold stock in the company, and of course every single member of our team, almost all of whom own shares themselves. That fact says a great deal about what this company produces and about our capacity to keep hitting the steady objectives we've laid out. Back in 2026, we lifted our targets. Going forward, it's our expectation that we'll keep driving past them throughout 2027 and 2028, and we remain on track toward the $250 million EBITDA figure for 2028. To all of you, we're grateful and thankful that you're traveling this path alongside us, and we look forward to the next call.
Operator
operatorThanks a lot; that concludes our session for today. We're grateful for the time you've given and for joining in. At this point, feel free to hang up.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Abacus Global Management, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Abacus Global Management, Inc. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Abacus Global Management, Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.